Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are naturally occurring hormones that regulate appetite, insulin secretion, and metabolism
This protein acted like a protective shield, preventing the kidneys from breaking the drug down and allowing it to circulate in the body for much longer
Compounded Tirzepatide Compounded tirzepatide activates GLP-1 and GIP receptors and is administered by subcutaneous injection
At standard doses, it is generally considered safe for the liver and kidneys in most patients
Human trials have reported good tolerability at doses up to 40mg/day, with only mild gastrointestinal effects occasionally observed at higher intake levels [16]
The process of PCT, which is done to ensure your body stays safe, is generally done as soon as the SARM has been completed